|本期目录/Table of Contents|

[1]张驰,张久荣,童维佳,等.芪胶升白胶囊对改善非小细胞肺癌患者化疗所致中性粒细胞减少症的临床药物疗效研究与分析[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):26-29.[doi:10.3969/j.issn.1672-271X.2018.01.006]
 ZHANG Chi,ZHANG Jiu-rong,TONG Wei-jia,et al.Study and analysis on clinical drug efficacy of Qijiaoshengbai capsule on the treatment of non-small cell lung cancer patients with neutropenia caused by chemotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(01):26-29.[doi:10.3969/j.issn.1672-271X.2018.01.006]
点击复制

芪胶升白胶囊对改善非小细胞肺癌患者化疗所致中性粒细胞减少症的临床药物疗效研究与分析()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第20卷
期数:
2018年01期
页码:
26-29
栏目:
出版日期:
2018-01-22

文章信息/Info

Title:
Study and analysis on clinical drug efficacy of Qijiaoshengbai capsule on the treatment of non-small cell lung cancer patients with neutropenia caused by chemotherapy
作者:
张驰张久荣童维佳牛素梅
作者单位:210029南京,南京市胸科医院药学部(张驰、童维佳、牛素梅),呼吸内科(张久荣)
Author(s):
ZHANG Chi1ZHANG Jiu-rong2TONG Wei-jia1NIU Su-mei1
(1. Department of Pharmacy, 2. Department of Respiration, the Thoracic Hospital in Nanjing,Nanjing 210029,Jiangsu,China)
关键词:
化疗芪胶升白胶囊非小细胞肺癌中性粒细胞减少症
Keywords:
chemotherapy Qijiaoshengbai capsule non-small cell lung cancer neutropenia
分类号:
R737.9
DOI:
10.3969/j.issn.1672-271X.2018.01.006
文献标志码:
A
摘要:
目的 探讨芪胶升白胶囊对改善非小细胞肺癌化疗患者中性粒细胞减少症的临床治疗效果。方法 选择南京市胸科医院收治的非小细胞肺癌化疗患者150例,按照随机数字表法分为芪胶升白组和对照组,每组75例,给予对照组患者化疗,给予芪胶升白组患者化疗+芪胶升白胶囊治疗,观察2组患者化疗前后中性粒细胞水平变化,在试验过程中同时采取必要的药学监护。结果 芪胶升白组临床治疗总有效率显著优于对照组(81.33 vs 62.67%, P<0.05),芪胶升白组治疗后重度中性粒细胞减少症发生率显著少于对照组(5.33% vs 25.33%, P<0.05);芪胶升白组重度中性粒细胞减少症的持续时间为(1.37±0.56)d,显著短于对照组的(2.14±0.70)d,差异具有统计学意义(P<0.05);芪胶升白组生活质量改善率显著高于对照组(45.33% vs 25.33%,P<0.05)。结论 芪胶升白胶囊可提高化疗效果,降低中性粒细胞减少症的发生率,应用安全,不良反应小,值得临床大力推广。
Abstract:
Objective To discuss the clinical curative efficacy of Qijiaoshengbai capsule in improving the non-small cell lung cancer for patients with neutropenia caused by chemotherapy.Methods 150 patients with non-small cell lung cancer chemotherapy admitted to Nanjing Chest hospital were selected and were randomly divided into study group and control group with 75 cases in each group. The patients in the control group were treated with chemotherapy, and the patients in the study group were treated with chemotherapy combined with Qijiaoshengbai Capsule. The changes of neutrophils in the two groups before and after chemotherapy were observed with necessary pharmaceutical care adopted in the process of experiment.Results The total effective rate of clinical treatment in study groupwas significantly better than that of the control group (81.33% vs 62.67%,P<0.05). The incidence of posttreatment severe neutropenia in the study group was significantly less than that of the control group ((5.33% vs 25.33%,P<0.05). The duration of severe neutropenia in the study group was (1.37±0.56)d, which was significantly shorter than (2.14±0.70)d in the control group and the difference was statistically significant (P<0.05). The ratio of life quality improvement of the study group was significantly higher than that of the control group(45.33% vs 25.33%,P<0.05).Conclusion Qijiaoshengbai Capsule can improve the efficacy of chemotherapy, reduce the incidence of neutropenia and ease toxic side effect. As a result, it is worthy of clinical promotion.

参考文献/References:

[1]袁香梅.芪精升白颗粒防治非小细胞肺癌患者化疗所致中性粒细胞减少症的临床观察[D].乌鲁木齐:新疆医科大学,2016.[2]丁荣楣,王平,马丽君,等.芪胶升白胶囊对肺癌放疗患者白细胞减少的疗效及生存质量的影响[J].现代肿瘤医学,2016,24(3):400-403.[3]李冬梅,李炜青,刘顺清.芪胶升白胶囊治疗白细胞减少症的疗效观察[J].临床医药文献电子杂志,2016,3(11):2195-2196.[4]林琪,陈明聪,陈德连,等.TP方案联合芪胶升白胶囊治疗中晚期非小细胞肺癌的疗效观察[J].中国中医药科技,2016,23(3):327-328.[5]唐文,谭建玲,贾亮亮,等.芪胶升白胶囊辅助治疗白细胞减少症有效性的Meta分析[J].中国药房,2015,26(33):4672-4674.[6]麻宏亮,张洪涛. 化疗联合中药对中晚期非小细胞肺癌患者免疫功能和KPS评分的影响[J].海南医学,2014,25(15):2271-2272.[7]卢玮冬,左云,陆筱灵,等. 肺癌患者化疗相关呕吐前驱症状的筛选及其与化疗相关呕吐的关系[J].临床和实验医学杂志, 2017,16(8):821-823.[8]王莉彦,丰健宇,刘丹丹,等.芪胶升白胶囊对恶性肿瘤化疗患者红细胞ATP酶活性的影响[J].中国继续医学教育,2016,8(24):183-184.[9]王莉彦,丰健宇,刘丹丹,等.晚期肺癌化疗患者应用芪胶升白胶囊治疗对红细胞ATP酶活性的影响分析[J].中国卫生标准管理,2016,7(17):132-133.[10]张喜平,张翔,杨红健,等.多种口服升白药物治疗化疗相关白细胞减少症的实验研究[J].中国临床药理学与治疗学,2015,20(3):246-251.[11]罗莉,刘玉荣.三维适形放疗联合同步吉非替尼化疗对肺癌患者细胞因子CSF、TNF、IL-2的影响[J].临床和实验医学杂志, 2016,15(9):865-868.[12]石燕霞,冯鑫.肿瘤化疗中重组人粒细胞集落刺激因子对粒细胞减少症的疗效观察[J].中华临床医师杂志(电子版),2013,7(21):9768-9769.[13]穆振诺,迪丽达尔·斯地克,忙尼沙汗·阿不都拉,等. 进展期直肠癌术后同期放化疗与单纯化疗的疗效比较[J].医学研究生学报,2015,28(1):55-57.[14]陈刚,唐晓军,魏强,等. 超声造影评价肝动脉化疗栓塞联合微波消融治疗中晚期肝癌疗效[J].东南国防医药,2016,18(5):531-539.[15]魏凌,陈剑云.中小医院临床药师开展药学服务工作要点探讨[J].东南国防医药,2014,16(6):661-663.

相似文献/References:

[1]王学文.EB病毒淋巴增殖的治疗进展[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):325.
[2]蒋静.鼻咽癌化疗患者恶心呕吐的护理[J].医学研究与战创伤救治(原医学研究生学报),2009,11(05):404.
[3]沈 杰,马爱英,刘秋如,等.经皮微波凝固综合治疗转移性肝癌[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):19.
 SHEN Jie,MA Ai-ying,LIU Qiu-ru,et al.Percutaneous microwave coagulation comprehensive therapy for metastatic liver cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(01):19.
[4]陈争明,范静平,林顺涨,等.枢丹治疗鼻咽癌化疗消化道反应疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2008,10(03):206.
[5]丁涤非,王 莉,陆笼辉,等.伽玛刀联合化疗治疗小细胞肺癌回顾性分析[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):189.[doi:10.3969/j.issn.1672-271X.2014.02.025]
[6]黄迎娣,崔 蕾,黄利鸣综述,等.上皮间质转化与肿瘤耐药[J].医学研究与战创伤救治(原医学研究生学报),2014,16(06):624.[doi:10.3969/j.issn.1672-271X.2014.06.020]
[7]乐根明,朱燕,陈晨,等.食管癌放疗后局部淋巴结转移行伽马刀治疗联合化疗的疗效分析[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):268.[doi:10.3969/j.issn.1672-271X.2017.03.012]
 YUE Gen-ming,ZHU Yan,CHEN Chen,et al.Clinical analysis on the body gamma knife combined with chemotherapy foresophageal carcinoma complicated with loco-regional lymph node metastasis after radiotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(01):268.[doi:10.3969/j.issn.1672-271X.2017.03.012]
[8]张玲玲,孙晶晶,唐玉梅.1例肝脾T细胞淋巴瘤术后化疗期间的切口护理[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):418.[doi:10.3969/j.issn.1672-271X.2017.04.023]
[9]李 星综述,苏亦平审校.肿瘤患者卵巢储备功能受损机制及保护并促进生育力的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):60.[doi:10.3969/j.issn.1672-271X.2020.01.014]
 LI Xing reviewing,SUYi-ping checking.Research progress on ovarian reserve impairment and the preservation and promotion of fertility in tumor patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(01):60.[doi:10.3969/j.issn.1672-271X.2020.01.014]
[10]蔡猛,周光新.非小细胞肺癌骨转移的治疗研究进展[J].医学研究与战创伤救治(原医学研究生学报),2022,24(4):408.[doi:10.3969/j.issn.1672-271X.2022.04.015]
 CAI Meng,ZHOU Guang-xin.Research progress in the treatment of bone metastasis in non-small cell lung cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(01):408.[doi:10.3969/j.issn.1672-271X.2022.04.015]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2018-01-20